Revisiting the role of radical surgery in early stage prostate cancer

Med J Aust. 2005 Sep 19;183(6):286-7. doi: 10.5694/j.1326-5377.2005.tb07055.x.

Abstract

Is it time to walk the line between overtreating indolent disease and undertreating aggressive disease?

Publication types

  • Editorial

MeSH terms

  • Age Factors
  • Aged
  • Disease Progression
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Prostate-Specific Antigen / blood
  • Prostatectomy / trends*
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / diagnosis
  • Prostatic Neoplasms / surgery*
  • Treatment Outcome

Substances

  • Prostate-Specific Antigen